Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 104 participants.
Also called NCT07241338
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 104 participants
- Sponsor
- Jing Liu
- Registry
-
NCT07241338
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07241338. Randomized; no masking; primary purpose treatment. Start 2025-11 (anticipated); primary completion 2026-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity
- Acronym
- SHOT
- Condition
- Hypertension
- Intervention (Drug)
- sacubitril/allisartan
- Intervention (Drug)
- Amlodipine
- Lead sponsor
- Jing Liu
Record details
- Record id
cardio:ct-nct07241338- Content hash
d05bc4281eaa0f8a3bc22a7cc72659fea31341d0228249c41927c8ade9fef678